We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Infinity Pharmaceuticals (INFI) Looks Good: Stock Jumps 19%
Infinity Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise over 19% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This reverses the recent trend for the company, as the stock is now down nearly 36% since Mar 29.
The company has seen one positive estimate revision in the last 30 days and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Currently, Infinity Pharmaceuticals sports a Zacks Rank #1 (Strong Buy).
Infinity Pharmaceuticals, Inc. Price
Infinity Pharmaceuticals, Inc. Price | Infinity Pharmaceuticals, Inc. Quote
Another similarly-ranked stock in the same industry is Grifols, S.A. (GRFS - Free Report) . You can see the complete list of today’s Zacks #1 Rank stocks here.
Is INFI going up? Or down? Predict to see what others think: Up or Down
Sell These Stocks. Now.
Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These are sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500. See today's Zacks "Strong Sells" absolutely free >>.